Treatment of Great Saphenous Vein Varicosities | Clinical Trial | StuddyBuddy@endsection
← Back to all trials
Completed
NCT05655416
Treatment of Great Saphenous Vein Varicosities
Conditions: Varicose Veins
Ages: 20 Years – 60 Years
Phase: NA
Enrollment: 55
Sponsor: Al-Azhar University
Location: Egypt
Summary
Venous insufficiency at lower extremities may result in clinical problems from cosmetic issues to ulcerations.
When the frequency of venous insufficiency and its related problems are considered besides their diversity, it is encountered as a public health issue.
This pathology is reported to affect 40% of women and 20% of men.1 Patients with varicose veins may complain of unsightly appearance, aching, heaviness, pruritus, and early fatigue of the affected leg.
These symptoms worsen with prolonged standing and sitting and are relieved by elevation of the leg above the level of the heart.
Also, mild edema is often present.
More severe signs include thrombophlebitis, hyperpigmentation, lipodermatosclerosis, ulceration, and bleeding
Eligibility Criteria
Inclusion Criteria:Patients presented by primary VV of the LL complaining of Leg pain cosmetic disfigurement, leg ulcer, itching, or pigmentation at LLthe incompetence of the saphenofemoral junction (SFJ) and or saphenopopliteal junction (SPJ).Exclusion Criteria:Lower limb involvement by any of the following conditions; secondary VV, recurrent VV, lymphedema, acute superficial thrombophlebitis, arterio-venous fistula (congenital or acquired), congenital anomalies of the venous system, general comorbidities, skin infection or ischemia
Source: ClinicalTrials.gov (NCT05655416). StuddyBuddy aggregates publicly available trial information.